Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: the impact of inappropriate empirical treatment
04 July 2019
There is scarce information on the prognosis of urinary tract infections (UTI) caused by KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp).
This is a retrospective observational study of hospitalized patients with urinary tract infections due to K. pneumoniae. We explored clinical failure at day 21 and 30-day all-cause mortality using different models of adjusted analysis.
KPC-Kp UTI is associated with higher clinical failure and may be due to an increase in inappropriate empirical treatment.
Further reading: Journal of Infection
Author(s): Jorge Rodriguez-Gómez, Elena Pérez-Nadales, Belen Gutiérrez-Gutiérrez, Isabel Machucad, Luis Martinez-Martineze, Francisco Rivera, Angela Canod, Juan Jose Castóna, Juan Carlos Roblesa, Carmen De la Fuente, Fernando Rodríguez-López, Jesus Rodriguez-Bañoc, Jesus Rodriguez-Baño, Julian Torre-Cisnerosa
Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
